GLP-1s continue to make headlines as miracle weight loss drugs, so it's no surprise that employee demand for these medications is rising. Employees increasingly expect organizations to provide access to GLP-1s. Yet, many employers struggle to find a way to balance the needs of their workforce with the steep cost of the medications.
Additionally, once employees are on a GLP-1, they don't always stick to their treatment plan, often discontinuing the medication before they achieve the desired results - and before employers realize ROI. This study breaks down one solution for helping organizations end the GLP-1 cost cycle, boost employee persistence, and achieve long-term cost savings.